Market Research Logo

Partnerships, Licensing, Investments and M&A Deals and Trends for 2018 in Pharmaceuticals

Partnerships, Licensing, Investments and M&A Deals and Trends for 2018 in Pharmaceuticals

Summary

GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends for 2018 in Pharmaceuticals, report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in 2018. The report portrays detailed comparative data on the number of deals and their value in the last five years, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

Scope

  • Analysis of the market trends for the pharmaceutical industry in the global arena.
  • Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
  • Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
  • Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
  • Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
  • Analysis of partnership and licensing deals based on clinical stage of development of products.
  • Summary of the pharmaceutical deals globally in the five years.
  • Information on the top deals happened in the pharmaceutical industry.
  • Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
  • League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Reasons to buy
  • Enhance your decision making capability in a more rapid and time sensitive manner.
  • Find out the major deal performing segments for investments in your industry.
  • Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
  • Identify companies that are aggressively looking to raise capital in the market
  • Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
  • Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
  • Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
  • Identify growth segments and opportunities in each region within the industry.
  • Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.


  • Independent Pharmaceutical & Healthcare Research
    • M&A Trends and Analysis
      • Table Figure 1: Pharmaceutical & Healthcare, Number of Deals, 2014–2018
      • Table Figure 2: Pharmaceutical & Healthcare, Number of Deals by Type, 2014-2018
      • Table Figure 3: Pharmaceutical & Healthcare, Number of Deals by Therapy Area, 2018
  • Deal Values in Pharmaceutical & Healthcare Industry Increased in 2018
    • Pharmaceutical & Healthcare, Deals Summary, 2018
      • Table Figure 4: Pharmaceutical & Healthcare, Number of Deals by Region, 2018
  • Pharmaceutical & Healthcare, Global, Deals Summary
    • Pharmaceutical & Healthcare, Global, Deals Analysis, 2018
      • Table Figure 5: Pharmaceutical & Healthcare, Global, Number of Deals and Deal Value (US$ m), 2014- 2018
      • Table Pharmaceutical & Healthcare, Global, Deals Summary, Number of Deals and Deal Value (US$ m), 2014 - 2018
      • Pharmaceuticals & Healthcare, Global, Deals Analysis, 2018 by Quarter
        • Table Figure 6: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Value (US$ m), Q1 2018-Q4 2018
        • Table Pharmaceuticals & Healthcare, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2018-Q4 2018
    • Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, 2018
      • Table Figure 7: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), 2018
    • Pharmaceuticals & Healthcare, Global, by Type, Deal Values, 2018
      • Table Figure 8: Pharmaceuticals & Healthcare, Global, Deal Values (%), 2018
      • Table Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), 2018
    • Pharmaceuticals & Healthcare, Global, Top Deals, 2018
      • Table Pharmaceuticals & Healthcare, Top Deals, Global, 2018
    • Pharmaceuticals & Healthcare, Top Deals, Global, Summaries, 2018
      • Takeda Pharma Acquires Shire
      • Cigna Acquires Express Scripts Holding Company for USD67 Billion
      • Takeda Pharma to Raise up to USD20 Billion in Private Placement of Bonds
      • GlaxoSmithKline Acquires Remaining 36.5% Stake in GlaxoSmithKline Consumer Healthcare from Novartis for USD13 Billion
      • Sanofi Acquires Bioverativ for USD11.5 Billion in Tender Offer
      • Celgene Acquires Juno Therapeutics for USD9 Billion
      • Novartis Acquires AveXis for USD8.7 Billion
      • Celgene Acquires Impact Biomedicines for up to USD7 Billion
      • Eisai Enters into Co-Development and Co-Commercialization Agreement with Merck
      • GlaxoSmithKline Acquires TESARO
  • Pharmaceuticals & Healthcare, Global, Deal Summary, by Type
    • Pharmaceuticals & Healthcare, Global, M&A, 2018
      • Table Figure 9: Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$ m), 2014 - 2018
      • Table Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), 2014 - 2018
      • Pharmaceuticals & Healthcare, Global, M&A, 2018 by Quarter
        • Table Figure 10: Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
        • Table Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
      • Top M&A Deals in 2018
        • Table Pharmaceuticals & Healthcare, Global, Top M&A Deals, 2018
      • Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, 2018
        • Table Figure 11: Pharmaceuticals & Healthcare, Global, M&As, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2018
        • Table Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, 2018
    • Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2018
      • Table Figure 12: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), 2014 – 2018
      • Table Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), 2014 - 2018
      • Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2018 by Quarter
        • Table Figure 13: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
        • Table Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
      • Pharmaceuticals & Healthcare, Global, IPO Deals, 2018
        • Table Figure 14: Pharmaceuticals & Healthcare, Global, IPO Deals, Number of Deals and Deal Value (US$ m), 2014 - 2018
        • Table Pharmaceuticals & Healthcare, Global, IPO Deals, Deals Summary, Number of Deals and Deal Value (US$ m), 2014 - 2018
      • Top IPOs in 2018
        • Table Pharmaceuticals & Healthcare, Global, Top IPOs, 2018
      • Pharmaceuticals & Healthcare, Global, Secondary Offerings Deals, 2018
        • Table Figure 15: Pharmaceuticals & Healthcare, Global, Secondary Offerings Deals, Number of Deals and Deal Value (US$ m), 2014 – 2018
        • Table Pharmaceuticals & Healthcare, Global, Secondary Offerings, Deals Summary, Number of Deals and Deal Value (US$ m), 2014 - 2018
      • Top Secondary Offerings in 2018
        • Table Pharmaceuticals & Healthcare, Global, Top Secondary Offerings, 2018
      • Pharmaceuticals & Healthcare, Global, PIPE Deals, 2018
        • Table Figure 16: Pharmaceuticals & Healthcare, Global, PIPE Deals, Number of Deals and Deal Value (US$ m), 2014 - 2018
        • Table Pharmaceuticals & Healthcare, Global, PIPEs, Deals Summary, Number of Deals and Deal Value (US$ m), 2014 - 2018
      • Top PIPE Deals in 2018
        • Table Pharmaceuticals & Healthcare, Global, Top PIPE Deals, 2018
      • Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, 2018
        • Table Figure 17: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2018
        • Table Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), 2018
    • Pharmaceuticals & Healthcare, Global, Debt Offering Deals, 2018
      • Table Figure 18: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Number of Deals and Deal Values (US$ m), 2014 – 2018
      • Table Pharmaceuticals & Healthcare, Global, Debt Offering, Deals Summary, Number of Deals and Deal Values (US$ m), 2014 - 2018
      • Pharmaceuticals & Healthcare, Global Debt Offerings, 2018 by Quarter
        • Table Figure 19: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
        • Table Pharmaceuticals & Healthcare, Global, Debt Offering, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
      • Pharmaceuticals & Healthcare, Global, Public Debt Offerings, 2018
        • Table Figure 20: Pharmaceuticals & Healthcare, Global, Public Debt Offering Deals, Number of Deals and Deal Value (US$ m), 2014 – 2018
        • Table Pharmaceuticals & Healthcare, Global, Public Debt Offerings, Deals Summary, Number of Deals and Deal Value (US$ m), 2014 - 2018
      • Top Public Debt Offerings in 2018
        • Table Pharmaceuticals & Healthcare, Global, Top Public Debt Offerings, 2018
      • Pharmaceuticals & Healthcare, Global, Private Debt Placements, 2018
        • Table Figure 21: Pharmaceuticals & Healthcare, Global, Private Debt Placements, Number of Deals and Deal Value (US$ m), 2014 – 2018
        • Table Pharmaceuticals & Healthcare, Global, Private Debt Placements, Deals Summary, Number of Deals and Deal Value (US$ m), 2014 - 2018
      • Top Private Debt Placements in 2018
        • Table Pharmaceuticals & Healthcare, Global, Top Private Debt Placements, 2018
      • Pharmaceuticals & Healthcare, Global, Debt Offering Deals, by Therapy Area, 2018
        • Table Figure 22: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2018
        • Table Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Summary, Number of Deals and Deal Values (US$ m), 2018
    • Pharmaceuticals & Healthcare, Global, Partnership Deals, 2018
      • Table Figure 23: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), 2014 - 2018
      • Table Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), 2014 - 2018
      • Pharmaceuticals & Healthcare, Global, Partnership Deals, 2018 by Quarter
        • Table Figure 24: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
        • Table Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2018–Q4 2018
        • Table Figure 25: Pharmaceuticals & Healthcare, Global, Partnership Deals Break down (%), 2018
      • Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, 2018
        • Table Figure 26: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2018
        • Table Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2018
      • Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Value (US$ m), 2018
        • Table Figure 27: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront & Milestone Payments and Deal Values (US$ m), 2018
        • Table Pharmaceuticals & Healthcare, Partnership Deals, Upfront & Milestone Payment and Deal Values (US$ m), 2018
      • Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2018
        • Table Figure 28: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2018
        • Table Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2018
      • Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, 2018
        • Table Figure 29: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, 2018
      • Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), 2018
        • Table Figure 30: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, 2018
        • Table Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, 2018
      • Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2018
        • Table Figure 31: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2018
        • Table Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payment and Deal Values (US$ m), 2018
      • Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, 2018
        • Table Pharmaceuticals & Healthcare, Global, Partnerships, Upfront & Milestone Payment and Deal Values (US$ m), 2018
      • Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, 2018
        • Table Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, 2018
      • Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payment, 2018
        • Table Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payment, 2018
    • Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2018
      • Table Figure 32: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), 2014 – 2018
      • Table Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), 2014 - 2018
      • Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2018 by Quarter
        • Table Figure 33: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
        • Table Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018–Q4 2018
      • Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, 2018
        • Table Figure 34: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Number of Deals and Deal Values (US$ m), 2018
        • Table Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Number of Deals and Deal Values (US$ m), 2018
      • Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Upfront & Milestone Payments and Deal Value (US$ m), 2018
        • Table Figure 35: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Upfront & Milestone Payments and Deal Values (US$ m), 2018
        • Table Pharmaceuticals & Healthcare, Licensing Agreements, Upfront & Milestone Payments and Deal Values (US$ m), 2018
      • Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2018
        • Table Figure 36: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2018
        • Table Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Upfront & Milestone Payments and Deal Values (US$ m), 2018
      • Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Number of Deal Values (US$ m), 2018
        • Table Figure 37: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Number Of Deals, 2018
      • Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), 2018
        • Table Figure 38: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Deal Values (US$ m), 2018
        • Table Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q4 2015 - Q4 2018
      • Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2018
        • Table Figure 39: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, by Upfront & Milestone Payment and Deal Values (US$ m), 2018
        • Table Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Upfront & Milestone Payments and Deal Values (US$ m), 2018
      • Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Values, 2018
        • Table Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Values (US$ m), 2018
      • Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Upfront Payment, 2018
        • Table Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Upfront Payment, 2018
      • Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Milestone Payment, 2018
        • Table Pharmaceutical & Healthcare, Global, Top Licensing Agreements, by Milestone Payment, 2018
    • Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2018
      • Table Figure 40: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), 2014 - 2018
      • Table Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), 2014 - 2018
      • Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2018 by Quarter
        • Table Figure 41: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
        • Table Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
      • Top Private Equity Deals in 2018
        • Table Pharmaceuticals & Healthcare, Global, Top Private Equity Deals, 2018
      • Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, 2018
        • Table Figure 42: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2018
        • Table Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$ m), 2018
    • Pharmaceuticals & Healthcare, Global, Venture Capital Deals, 2018
      • Table Figure 43: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), 2014 - 2018
      • Table Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), 2014 - 2018
      • Pharmaceuticals & Healthcare, Global, Venture Financing Deals, 2018 by Quarter
        • Table Figure 44: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
        • Table Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
      • Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number of Deals(%) 2018
        • Table Figure 45: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals (%), 2018
      • Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, 2018
        • Table Figure 46: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Deal Values (%), 2018
        • Table Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals and Deal Values (%), 2018
      • Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, 2018
        • Table Figure 47: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2018
        • Table Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$ m), 2018
      • Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Last One Year
        • Table Pharmaceutical & Healthcare, Global, Top VC Backed Companies, 2018
      • Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, 2018
        • Table Figure 48: Pharmaceuticals & Healthcare, Top Venture Financing Firms, Global, Number of Deals and Deal Value (US$ m), 2018
        • Table Pharmaceuticals & Healthcare, Top Venture Financing Firms, Global, Number of Deals and Deal Value (US$ m), 2018
      • Top Venture Financing Deals in 2018
        • Table Pharmaceuticals & Healthcare, Top Venture Financing Deals, Global, 2018
  • Pharmaceuticals & Healthcare, Global, Deal Summary, By Market
    • Pharmaceuticals & Healthcare, Global, Oncology Deals, 2018
      • Table Figure 49: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), 2014 - 2018
      • Table Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), 2014 - 2018
      • Pharmaceuticals & Healthcare, Global, Oncology Deals, 2018 by Quarter
        • Table Figure 50: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
        • Table Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
      • Oncology - Deals of the Year
    • Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2018
      • Table Figure 51: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), 2018, 2014 – 2018
      • Table Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), 2014 – 2018
      • Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2018 by Quarter
        • Table Figure 52: Pharmaceuticals & Healthcare, Central Nervous System, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
        • Table Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
      • Central Nervous System - Deals of the Year
    • Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2018
      • Table Figure 53: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Value (US$ m), 2014 – 2018
      • Table Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), 2014 – 2018
      • Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2018 by Quarter
        • Table Figure 54: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Value (US$ m), Q1 2018- Q4 2018
        • Table Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
      • Infectious Disease - Deals of the Year
    • Pharmaceuticals & Healthcare, Global, Immunology Deals, 2018
      • Table Figure 55: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), 2014 - 2018
      • Table Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), 2014 – 2018
      • Pharmaceuticals & Healthcare, Global, Immunology Deals, 2018 by Quarter
        • Table Figure 56: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
        • Table Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
      • Immunology - Deals of the Year
    • Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2018
      • Table Figure 57: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), 2014 - 2018
      • Table Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), 2014 – 2018
      • Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2018 by Quarter
        • Table Figure 58: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
        • Table Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
      • Cardiovascular - Deals of the Year
    • Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2018
      • Table Figure 59: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), 2014 – 2018
      • Table Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), 2014 – 2018
      • Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2018 by Quarter
        • Table Figure 60: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
        • Table Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
      • Metabolic Disorders - Deals of the Year
    • Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2018
      • Table Figure 61: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), 2014 – 2018
      • Table Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), 2014 – 2018
      • Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2018 by Quarter
        • Table Figure 62: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
        • Table Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2018-Q4 2018
      • Gastrointestinal - Deals of the Year
  • Pharmaceuticals & Healthcare, Deal Summary, By Geography
    • Pharmaceuticals & Healthcare, North America Region, Deals, 2018
      • Table Figure 63: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Value (US$ m), 2014 - 2018
      • Table Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Value (US$ m), 2014 - 2018
      • Pharmaceuticals & Healthcare, North America Region, Deals, 2018 by Quarter
        • Table Figure 64: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Value (US$ m), Q1 2018–Q4 2018
        • Table Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Value (US$ m), Q1 2018–Q4 2018
      • North America – Deals of the Year
    • Pharmaceuticals & Healthcare, European Region Deals, 2018
      • Table Figure 65: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Value (US$ m), 2014 - 2018
      • Table Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Value (US$ m), 2014 - 2018
      • Pharmaceuticals & Healthcare, Europe, Deals, 2018 by Quarter
        • Table Figure 66: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Value (US$ m), Q1 2018–Q4 2018
        • Table Pharmaceuticals & Healthcare, European Region Deals, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2018-Q4 2018
      • Europe – Deals of the Year
    • Pharmaceuticals & Healthcare, Asia-Pacific Region, Deals, 2018
      • Table Figure 67: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Value (US$ m), 2014 - 2018
      • Table Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Value (US$ m), 2014 – 2018
      • Pharmaceuticals & Healthcare, Asia-Pacific Region Deals, 2018 by Quarter
        • Table Figure 68: Pharmaceuticals & Healthcare, Asia-Pacific Region, Deals, Number of Deals and Deal Value (US$ m), Q1 2018– Q4 2018
        • Table Pharmaceuticals & Healthcare, Asia-Pacific Region Deals, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2018-Q4 2018
      • Asia-Pacific – Deals of the Year
    • Pharmaceuticals & Healthcare, Rest of the World (ROW) Deals, 2018
      • Table Figure 69: Pharmaceuticals & Healthcare, Rest of the World Deals, Number of Deals and Deal Value (US$ m), 2014 - 2018
      • Table Pharmaceuticals & Healthcare, Rest of the World Deals, Deals Summary, Number of Deals and Deal Value (US m), 2014 – 2018
      • Pharmaceuticals & Healthcare, Rest of the World Deals, 2018 by Quarter
        • Table Figure 70: Pharmaceuticals & Healthcare, Rest of the World Deals, Number of Deals and Deal Value (US$ m), Q1 2018–Q4 2018
        • Table Pharmaceuticals & Healthcare, Rest of the World Deals, Deals Summary, Number of Deals and Deal Value (US$ m), Q1 2018–Q4 2018
      • Rest of the World – Deals of the Year
  • Pharmaceuticals & Healthcare, Global, Top Financial Advisors
    • Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, 2018
      • Table Figure 71: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Value (US$ m), 2018
      • Table Pharmaceuticals & Healthcare, Global,, Top Financial Advisors, M&A, Number of Deals and Deal Value (US$ m), 2018
    • Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, 2018
      • Table Figure 72: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Value (US$ m), 2018
      • Table Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Value (US$ m), 2018
  • FurtherInformation
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclosure information
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report